Immuron Ltd (IMRN)
1.93
-0.05
(-2.53%)
USD |
NASDAQ |
Nov 14, 16:00
1.93
0.00 (0.00%)
After-Hours: 20:00
Immuron Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.0033 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| December 31, 2019 | 0.0143 |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.0093 |
| June 30, 2017 | 0.0556 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2020
0.0143
Maximum
Dec 2019
0.0018
Average
--
Median
Jun 2020
Debt to Equity Ratio Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | -- |
| Immutep Ltd | -- |
| Opthea Ltd | -1.867 |
| Mesoblast Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.39M |
| Total Liabilities (Quarterly) | 1.899M |
| Shareholders Equity (Quarterly) | 8.495M |
| Current Ratio | 5.456 |